Protagonist Therapeutics Inc (PTGX)
43.36
-3.14
(-6.74%)
USD |
NASDAQ |
Nov 12, 15:07
Protagonist Therapeutics Revenue (Annual): 60.00M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 60.00M |
December 31, 2022 | 26.58M |
December 31, 2021 | 27.36M |
December 31, 2020 | 28.63M |
Date | Value |
---|---|
December 31, 2019 | 0.231M |
December 31, 2018 | 30.92M |
December 31, 2017 | 20.06M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.231M
Minimum
2019
60.00M
Maximum
2023
28.56M
Average
27.36M
Median
2021
Revenue (Annual) Benchmarks
Johnson & Johnson | 85.16B |
Assembly Biosciences Inc | 7.163M |
Precision BioSciences Inc | 48.73M |
Entrada Therapeutics Inc | 129.01M |
NovaBay Pharmaceuticals Inc | 14.73M |